Oral GnRH-Ant Elagolix to Patients With Surgically Diagnosed Endometriosis – RBMO
Reproductive BioMedicine Online shared a post on LinkedIn about a paper by Eric S. Surrey et al. published in RBMO:
“This prospective, randomized, pilot trial demonstrates that administration of the oral GnRH-ant elagolix to patients with surgically diagnosed endometriosis for 56 days before euploid embryo transfer resulted in highly encouraging outcomes that were not only non-inferior but apparently equivalent to a similar group of patients reviewing a parenteral GnRHa for a similar time period.
Authors Eric Surrey, Mandy Katz-Jaffe, Laxmi A Kondapalli, William Schoolcraft, and Rachel Makloski say that, if these results are confirmed in larger scale appropriately designed trials, this agent could be a more tolerable substitute for long acting GnRHa as has been suggested in trials of symptomatic endometriosis patients – the development of non-invasive serum or endometrial markers to determine which patients would be most likely to benefit from this treatment would be invaluable.
Selected as an Editor’s Choice article from our December issue, the paper can be read in full for free, now.”
Title: Prolonged oral GnRH-antagonist administration before euploid embryo transfer in patients with endometriosis: a prospective randomized pilot non-inferiority trial
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 12, 2026, 17:02Are You Passionate About Patient Safety and Communication in Healthcare? – RCOG
-
Jul 12, 2026, 17:00Christopher Robinson: Ultrasound-Guided HIFU in Early-Onset Twin-Twin Transfusion Syndrome
-
Jul 12, 2026, 16:59Addressing Sexual Violence, A FIGO Committee on Women Facing Crises Consensus Statement – IJGO
-
Jul 12, 2026, 16:57Clinician vs. Embryologist, Same Cycle, Different Windows into Biology – Indore Infertility Clinic and IVF Center
-
Jul 12, 2026, 16:56Marco Zaccaria: Understanding Uterine Fibroids Through Nutrition and Lifestyle!
-
Jul 12, 2026, 16:54Camille Clare: ACOG Begins New Leadership Chapter with Inaugural Board Meeting!
-
Jul 12, 2026, 16:53Sandro Esteves: Scientific Exchange and Innovation in Male Fertility at London’s IVF Masterclass
-
Jul 12, 2026, 16:51George Woodhead: Sharing Our Work on Cryotransport of Vitrified Donor Oocytes at ESHRE!
-
Jul 12, 2026, 16:49How ESHRE 2026 Is Shaping the Future of Reproductive Medicine? – Umana Fertility